Spots Global Cancer Trial Database for Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
Official Title: A Randomized Double-masked, Phase III Study Assessing Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Visual Impairment Due to Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) [Blossom]
Study ID: NCT01976338
Study Description
Brief Summary: Provided efficacy and safety data on intravitreal injections of ranibizumab 0.5 mg in patients with visual impairment due to macular edema secondary to BRVO
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Novartis Investigative Site, Beijing, Beijing, China
Novartis Investigative Site, Beijing, Beijing, China
Novartis Investigative Site, Chongqing, Chongqing, China
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Shantou, Guangdong, China
Novartis Investigative Site, Harbin, Heilongjiang, China
Novartis Investigative Site, Wuhan, Hubei, China
Novartis Investigative Site, Changsha, Hunan, China
Novartis Investigative Site, Nanjing, Jiangsu, China
Novartis Investigative Site, Nanjing, Jiangsu, China
Novartis Investigative Site, Nantong, Jiangsu, China
Novartis Investigative Site, Nanchang, Jiangxi, China
Novartis Investigative Site, Qingdao, Shandong, China
Novartis Investigative Site, Chengdu, Sichuan, China
Novartis Investigative Site, Tianjin, Tianjin, China
Novartis Investigative Site, Tianjin, Tianjin, China
Novartis Investigative Site, Wenzhou, Zhejiang, China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Chongqing, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Hongkong, , Hong Kong
Novartis Investigative Site, Bandung, Jawa Barat, Indonesia
Novartis Investigative Site, Jakarta, , Indonesia
Novartis Investigative Site, Manila, Metro Manila, Philippines
Novartis Investigative Site, San Juan City, , Philippines
Novartis Investigative Site, Kaohsiung, , Taiwan
Novartis Investigative Site, Lin-Kou, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Hanoi, , Vietnam
Novartis Investigative Site, Ho Chi Minh City, , Vietnam
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
